TerminatedPhase 4NCT00194857
Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Studying Acquired neutropenia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Weill Medical College of Cornell University
- Principal Investigator
- Andrew Talal, MDWeill Medical College of Cornell University
- Intervention
- erythropoietin, GCSF(drug)
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2002 – 2005
Study locations (1)
- Weill Medical College of Cornell University, New York, New York, United States
Collaborators
Schering-Plough
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00194857 on ClinicalTrials.govOther trials for Acquired neutropenia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsX4 Pharmaceuticals
- RECRUITINGPHASE1, PHASE2NCT00967785A Phase I Study of Mozobil in the Treatment of Patients With WHIMSNational Institute of Allergy and Infectious Diseases (NIAID)